The FDA Shake-Up Continues, And Could Impact Genetic Medicines

investors.com/news/technology/vinay-prasad-fda-officials-ousted-nicole-verdun-rachael-anatol

The latest shake-up at the FDA forced out the top two officials in charge of reviewing cell and gene therapies, analysts said.
The post The FDA Shake-Up Continues, And Could Impact Genetic Medicines appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-06-20 14:26:41.
The Entire Business World on a Single Page. Free to Use →